Innovative Medical and Surgical Devices
The CTTM transforms ideas, research results and new knowledge into innovative solutions, products and devices for patients.
Treatment for bioartificial pancreas (Mailpan®)
With the CeeD and Statice companies, the CTTM has co-invented the macroencapsulation device for pancreatic islets or Mailpan® bioartificial pancreas.
The CTTM has developed, designed and now produces the semi-permeable membrane treatment that composes the device's structure
The treatment purpose is for the membrane to be implanted under the best safety and performance conditions:
- Cells colonization control
- Preserved porosity
- Bioactivity: revascularization, limited inflammation
The CTTM is the co-founder of the start-up Defymed, which will carry on the clinical investigations and will sell the bioartifical pancreas.
"Research that has changed our lives". Report by Sophie Bécherel (France Inter)